CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) FY2026 YTD Q2 Statement of Cash Flows
2025-12-28 to 2026-06-27
Statement of Cash Flows
2025-12-28 to 2026-06-27
Swipe to see the full flow
Chart details
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. cash flow reconciliation, Dec 28, 2025 through Jun 27, 2026
Cash flows for Dec 28, 2025 through Jun 27, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 27, 2025. Ending cash: Jun 27, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.
- Beginning cash on Dec 27, 2025
- 215,997,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- Operating activities
- 220,802,000 US dollars. Net cash provided.
- Net income (loss)
- negative 15,562,000 US dollars
- Depreciation and amortization
- 134,441,000 US dollars
- Long-lived asset impairments
- 26,279,000 US dollars
- Stock-based compensation
- 42,162,000 US dollars
- Deferred income taxes
- 12,077,000 US dollars
- Write down of inventories
- 3,165,000 US dollars
- (Gains) losses and impairments on venture capital and strategic equity investments, net
- negative 6,936,000 US dollars
- Provision for credit losses
- 1,124,000 US dollars
- (Gain) loss on divestitures, net
- 181,386,000 US dollars
- Other, net
- negative 12,595,000 US dollars
- Trade receivables and contract assets, net
- negative 87,135,000 US dollars
- Inventories
- 43,747,000 US dollars
- Accounts payable
- 21,276,000 US dollars
- Accrued compensation
- negative 64,858,000 US dollars
- Deferred revenue
- 5,593,000 US dollars
- Customer contract deposits
- negative 4,543,000 US dollars
- Other assets and liabilities, net
- negative 20,335,000 US dollars
- Gain on sale of assets
- negative 38,484,000 US dollars
- Investing activities
- negative 379,748,000 US dollars. Net cash used.
- Acquisition of businesses and assets, net of cash acquired
- negative 467,254,000 US dollars
- Capital expenditures
- negative 87,013,000 US dollars
- Purchases of investments and contributions to venture capital investments
- negative 11,805,000 US dollars
- Proceeds from sale of investments
- 11,059,000 US dollars
- Proceeds from sale of businesses and assets, net
- 176,563,000 US dollars
- Other, net
- negative 1,298,000 US dollars
- Financing activities
- 183,063,000 US dollars. Net cash provided.
- Proceeds from long-term debt and revolving credit facility
- 1,265,258,000 US dollars
- Payments on long-term debt, revolving credit facility, and finance lease obligations
- negative 745,927,000 US dollars
- Proceeds from exercises of stock options
- 1,620,000 US dollars
- Purchase of treasury stock
- negative 323,881,000 US dollars
- Payments of contingent consideration
- negative 11,400,000 US dollars
- Purchase of remaining equity interests of other redeemable noncontrolling interest
- 0 US dollars
- Other, net
- negative 2,607,000 US dollars
- Operating adjustment reconciliation
- 471,250,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- financing gross reconciliation
- 1,266,878,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- investing gross reconciliation
- 567,370,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- Exchange-rate effect
- 467,000 US dollars
- Ending cash on Jun 27, 2026
- 240,581,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- Cash sources and uses
- 620,329,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- Net cash change
- 24,584,000 US dollars. Ending cash minus beginning cash.
- Cash flow / Net income
- Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.
- Operating cash flow
- 220,802,000 US dollars. Operating cash flow used in the free cash flow calculation.
- cash spent on productive assets
- 87,013,000 US dollars. These cash purchases are already included in investing activities above.
- Free cash flow
- 133,789,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.
Chart connections
- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net loss −$15.56M + net operating adjustments $236.36M = operating cash +$220.80M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash spent on productive assets equals free cash flow: 220,802,000 US dollars minus 87,013,000 US dollars equals 133,789,000 US dollars.
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!